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THE POLYENDOCRINE SYNDROMES
BOY FRAME,

M.D.*

Physicians are often too content after diagnosing hyperfunction of a single
endocrine organ. Such a diagnosis may be lacking in completeness. Evidence is
increasing that hyperfunction of one endocrine gland may be accompanied by other
endocrine hyperplasia and adenomas. Table I lists some of these polyendocrine
syndromes that have received recent attention. Several are undoubtedly related, while
others are separate and distinct entities.

Table I
1. Multiple endocrine adenoma-peptic ulcer complex ( M E A )
2. Zollinger-Ellison syndrome
3. Familial hyperparathyroidism
4. Hyperparathyroidism, hyperthyroidism and thyroid cancer
5. Familial pheochromocytoma
6. Cushing's disease and hyperparathyroidism
7. Carcinoid syndrome in noncarcinoid malignancies
8. Multiple hormone production in single nonendocrine
malignancies
Multiple Endocrine Adenoma-Peptic Ulcer Complex ( M E A )
During the past few years an opportunity was afforded to study a Negro family
with multiple endocrine adenomas and a high incidence of peptic ulcer.' Since peptic
ulcer and its complications were usually the presenting complaint and also the main
cause of death, peptic ulcer is considered an integral part of the denomination.
Forty-two members of a family over six generations were studied. Eleven members
were proved to have the syndrome while five were highly suspect. The study was
carried out with some difficulty since the family members live in widely separated
*Fifth Medical Division.
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areas of Detroit, Philadelphia and New York. The help of Dr. Harold Ballard of
New York City in this study and investigation is duly appreciated. Most of the
family was cooperative and wanted to know about any evidence of the condition.
Some members, however, were fearful that the syndrome might be present and did
not wish to know. The anxiety and concern in a family where such a serious
hereditary condition exists can be understood. A l l varieties of response can be seen
from complete denial to that of volunteering for medical research.
In addition to the afflicted family members, 74 additional cases of MEA were
found recorded in the hterature, making a total of 85 patients for analysis,' In 65%
of the cases, pituitary involvement was present. Chromophobe adenoma occurred
most commonly and usually resulted in symptoms of pituitary insufriciency. Acromegaly occurred in several instances in its classic form.
In 82% of the cases reviewed, pancreatic islet cell adenomas or malignancies
were found. These tumors ranged from a single large adenoma to multiple small
adenomas, both alpha and beta cell type. In the beta cell tumors, features of
hypoglycemia were usually present. Despite local or distant metastases in 21 instances,
metastatic spread of islet-cell tumor was responsible for death in only one patient.
Pancreatic islet cell carcinoma, when occurring with MEA, appears relatively benign
compared to the isolated acinar or single beta cell pancreatic carcinoma.
The parathyroid glands were involved in 88% of the cases. Fewer renal and
skeletal complications were observed than is usual in primary hyperparathyroidism.
The occurrence of renal lithiasis and nephrocalcinosis was 33% compared to an
incidence of 75 to 80% in most series of patients with primary hyperparathyroidism.
Skeletal involvement due to osteitis fibrosa is rarely seen in MEA. The incidence of
primary chief cell hyperplasia and multiple parathyroid adenomas was also much
higher than in primary hyperparathyroidism.
In 38% of the cases, adrenocortical involvement was proved at either operation
or necropsy and included general hyperplasia, nodular hyperplasia and cortical adenomas. Despite this pathologic evidence of endocrine hyperplasia, there was little
clinical or laboratory evidence of adrenocortical hyperfunction except in one patient
who had simultaneous aldosteronism and hyperparathyroidism.
The thyroid gland was involved in 19% of the cases, a higher incidence than
previously reported. Two patients showed symptoms and signs of thyrotoxicosis, and
one patient had a thyroid carcinoma. The remainder had one or more nonfunctioning
thyroid adenomas.
Peptic ulcer occurred in 49 of the 85 patients studied. More than half the ulcers
were multifocal in origin and often atypical in location. In the majority one or more
complications of ulcer such as hemorrhage, obstruction and perforation had occurred.
In 15 cases, gastric hypersecretion or gastric rugar hypertrophy could be demonstrated.
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Of theoretic interest is the relationship of the endocrine involvement to the ulcer
diathesis. Current evidence suggests that the gastrin-like material which has been
isolated from the pancreatic, non-beta cell tumors in a number of instances in MEA
is the most likely cause for the gastric hypersecretion and the peptic ulcer diathesis.
There is no substantial evidence of gastric hypersecretion occurring in hyperfunctioning
parathyroid states. I f hyperparathyroidism does increase the incidence of peptic ulcer
disease, it perhaps does so by altering the gastric mucosal barrier, although proof
is lacking. Parathyroid hormone has been shown to depolymerize the mucopolysaccharides in gastric mucin as well as in connective tissue throughout the body.
Serious diarrhea occurred in 11 of the 85 patients with MEA. Typically, the
stools in these patients were loose and watery and often were associated with evidence
of electrolyte depletion. In several instances, frank steatorrhea proved to be present.
The mechanisms of the diarrhea may be explained in several ways. The gastric
hyperacidity probably inactivates pancreatic lipase in the duodenal lumen and thereby
interferes with proper digestion of fats. Not all patients with diarrhea have had
gastric hypersecretion, however, and in at least one instance diarrhea has been relieved
by removal of a pancreatic islet cell tumor. Also, extracts of pancreatic islet cell
tumors in such patients have been shown to contain a substance which promotes bowel
activity in isolated guinea pig ileum. Since both intestinal and bronchial carcinoid
tumors may occur in MEA, and since the histology of islet cell tumors and carcinoid
tumors may be difficult to differentiate, it is possible that serotonin may be present
in sufficient amounts in some cases of MEA to promote peristaltic activity. Recent
work from this hospital has demonstrated elevated blood serotonin and histamine
levels in patients with Zollinger-Ellison and M E A syndromes, but diarrhea in these
patients was thought not due to the increased levels of serotonin.^ Other patients in
the future, however, may demonstrate such a relationship.
For some strange and unexplained reason, there seems to be an increased incidence
of lipomas in MEA. Eleven patients in the current review had lipomas, often multicentric and found in unusual locations such as the lung and retroperitoneal space.
It is of interest that a multiendocrine syndrome has been reported to occur
spontaneously in animals. Also, after exposure to large doses of Xrays, rats of
various ages may develop numerous multiendocrine tumors. The basic defect causing
adenomatosis of the endocrine glands is not known, but the high familial incidence
suggests a mutant gene that is readily transmittable. Hereditary studies available
at present indicate that transmission is along the lines of autosomal dominance with
a high degree of penetrance. Chromosomal studies performed on several members of
the family reported revealed normal karyotypes.
ZOLLINGER-ELLISON SYNDROME

It has been ten years since the Zollinger-Ellison syndrome was first described.'''
By definition this syndrome is characterized by gastric hyperacidity, severe peptic
ulceration with or without diarrhea and one or more non-beta islet cell tumors of the
pancreas. Long-term study of these patients indicates that many have underlying
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multiple endocrine gland involvement. Both MEA and the Zollinger-Ellison syndrome
undoubtedly have a common genetic background. With present information, it is
reasonable to assume that the Zollinger-Ellison syndrome is a special variant of the
more inclusive MEA-peptic ulcer complex. The Zollinger-Ellison tumor represents
the gastrin-secreting islet-cell tumor in MEA and very likely accounts for the high
incidence of peptic ulcer disease.
F A M I L I A L HYPERPARATHYROIDISM

Several families have been reported with a high incidence of peptic ulcer, kidney
stones or pancreatitis in which underlying primary hyperparathyroidism has been
present.'"' The histology of the parathyroid glands in these families has varied. Where
the parathyroids have demonstrated primary chief cell hyperplasia, the probability
of associated polyendocrine involvement increased.' Endocrine tumors often remain
dormant for many years and it is only by following patients through to operation or
necropsy that a final opinion regarding the association of multiple endocrine lesions
can be given.
HYPERPARATHYROIDISM, HYPERTHYROIDISM AND THYROID CANCER

Several instances of simultaneous hyperthyroidism and hyperparathyroidism are
recorded.''" Since both conditions may give rise to hypercalcemia, a problem in
differential diagnosis can occur. Most recordings of this combined endocrine hyperfunction have included no evidence of other endocrine involvement. It is not known
whether these examples of polyendocrine disease have occurred by chance or
are in some way related. Experimental evidence shows that a calcium-rich diet in
animals results in increased incidence of thyroid hyperplasia and adenomatous formation." Hellstrom records an increased number of adenomas and nodular changes in
the thyroid gland in patients with primary hyperparathyroidism.'^ Perhaps in some
instances such adenomatous changes progress to carcinoma. To support this concept,
Ehlenberg and associates reported an unexpectedly high incidence of thyroid carcinoma
in patients operated on for parathyroid adenoma.'^ In a series of 93 patients with
primary hyperparathyroidism, 7 patients (or 7.5%) were found at operation to have
associated thyroid carcinoma. This experience suggests that surgeons operating on
patients for parathyroid adenoma should carefully explore the thyroid glands in an
attempt to detect areas of early malignancy.
FAMILIAL PHEOCHROMOCYTOMA

Approximately 20 families have been reported with familial pheochromocytoma,
and in several of these families thyroid carcinoma and even parathyroid adenomas
have been found.'" Pheochromocytomas in these instances are frequently bilateral.
This entity is inherited as an autosomal dominant gene with a high penetrance similar
to that seen in MEA. Again the question arises as to whether we are dealing with
a separate polyendocrine syndrome or a variation of the multiple endocrine-peptic
ulcer complex. The fact that patients with familial pheochromocytoma have not had
an increased incidence of peptic ulcer suggests this is a separate polyendocrine
syndrome.
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PRIMARY HYPERPARATHYROIDISM AND CUSHING'S SYNDROME

Raker and associates have documented two patients with simultaneous occurrence
of primary hyperparathyroidism and Cushing's syndrome.'= Neither had a family
history to suggest hereditary tendency, peptic ulcer disease or other endocrine disorder.
Both hyperparathyroidism and Cushing's disease may cause bone disease, nephrocalcinosis and renal stones. There is little supporting evidence that hyperfunction of
the adrenal cortex can produce an elevation of the serum calcium; in fact, adrenocortical
hypofunction is more likely to be associated with hypercalcemia. Of special interest
is the 15-year-old girl who had biochemical evidence of simultaneous hyperparathyroidism and aldosteronism.' This is thought to be the only report of this endocrine
combination.
CARCINOID SYNDROME I N NONCARCINOID MALIGNANCIES

Intestinal and bronchial carcinoids, as mentioned previously, have been described
in association with the multiple endocrine adenoma-peptic ulcer complex.' Recent
evidence suggests that noncarcinoid tumors found in such organs as the pancreas,
lung and thyroid may be associated with the characteristic clinical and laboratory
features of the carcinoid syndrome." Of importance to the current discussion of
polyendocrine disease is the fact that 3 of 8 patients so described have had evidence
of other endocrine hyperfunction. In one patient, simultaneous Cushing's syndrome
was present, in another, hyperinsulinism and in a third, hyperparathyroidism. The
entire area of carcinoid syndrome and associated multiple endocrine hyperfunction
needs further investigation.
M U L T I P L E HORMONE PRODUCTION I N SINGLE NONENDOCRINE MALIGNANCIES

In recent years there have been numerous reports that malignant tumors from a
variety of nonendocrine sources may produce hormone-like substances such as insulin,
gastrin, parathyroid hormone, antidiuretic hormone, ACTH, TSH and chorionic
gonadotropin. In several cases, two separate hormone-like materials have been isolated
from a single tumor. Recently a patient with a malignant islet cell tumor of the pancreas
that produced three separate substances similar to ACTH, melanocyte-stimulating
hormone and gastrin, was reported." This illustrates another form of polyendocrine
disease where multiple hormones are synthesized and released from the cells of a
single malignant tumor. Other examples of this unusual polyhormonal syndrome will
undoubtedly be uncovered. The ability of a cancerous cell to produce a variety of
hormonal substances is intriguing and may hold a clue to the nature and control of
certain malignancies.
Delineation of the various polyendocrine syndromes is in its infancy. Exciting
advances in this area are awaited as assay methods for various hormones improve.
The number of possible combinations occurring as the result of hyperplasia and
adenomas in the endocrine glands, as well as those arising in malignant tumors of
nonendocrine tissue, staggers the imagination. I t is again emphasized that the physician
should not be content with diagnosis of hyperfunction in a single endocrine gland,
but should be continually on the alert for evidence of polyendocrine involvement.
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